Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Total 13F shares
-
1,463,592
-
Share change
-
+651,058
-
Total reported value
-
$11,124,205
-
Price per share
-
$7.60
-
Number of holders
-
27
-
Value change
-
+$4,972,528
-
Number of buys
-
20
-
Number of sells
-
10
Institutional Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q2 2019
As of 30 Jun 2019 Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,463,592 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Moors & Cabot, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, NUVEEN ASSET MANAGEMENT, LLC, CITADEL ADVISORS LLC, and Assenagon Asset Management S.A..
This table shows 27 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.